Unknown

Dataset Information

0

A novel NFIA gene nonsense mutation in a Chinese patient with macrocephaly, corpus callosum hypoplasia, developmental delay, and dysmorphic features.

ABSTRACT: BACKGROUND:NFIA gene (OMIM*600727) has been shown to be associated with a syndrome of central nervous system malformations (corpus callosum and ventriculomegaly) with or without urinary tract defects(BRMUTD) (OMIM#613735) with a low incidence. METHODS AND RESULTS:   We presented the clinical data of a 3-month-old Chinese infant with clinical features such as thin corpus callosum, ventriculomegaly, development delay, and dysmorphic features (macrocephaly, hypertelorism, slightly pointed chin, broad forehead, and large ears). Genomic DNA was extracted for Trio Whole Exome Sequencing. Preliminary genetic tests revealed one de novo heterozygous nonsense mutation c.220 C>T (p.Arg74Ter) of the NFIA gene (NM_005595). CONCLUSION: Genetic DNA sequencing is a crucial method for diagnosing BRMUTD. This approach enriches the genotype and spectrum of BRMUTD syndrome and the outcome of the patient.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC7667355 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A novel NFIA gene nonsense mutation in a Chinese patient with macrocephaly, corpus callosum hypoplasia, developmental delay, and dysmorphic features.

Zhang Yan Y   Lin Cai Mei CM   Zheng Xiao Lan XL   Abuduxikuer Kuerbanjiang K  

Molecular genetics & genomic medicine 20200914 11

<h4>Background</h4>NFIA gene (OMIM*600727) has been shown to be associated with a syndrome of central nervous system malformations (corpus callosum and ventriculomegaly) with or without urinary tract defects(BRMUTD) (OMIM#613735) with a low incidence. METHODS AND RESULTS:   We presented the clinical data of a 3-month-old Chinese infant with clinical features such as thin corpus callosum, ventriculomegaly, development delay, and dysmorphic features (macrocephaly, hypertelorism, slightly pointed c  ...[more]

Similar Datasets

Unknown Haploinsufficiency of ZNF462 is associated with craniofacial anomalies, corpus callosum dysgenesis, ptosis, and developmental delay.
| S-EPMC5567153 | biostudies-literature
Unknown Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis.
| S-EPMC5096508 | biostudies-literature
Unknown Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum.
| S-EPMC3769928 | biostudies-literature
Unknown Whole-exome sequencing identifies mutated c12orf57 in recessive corpus callosum hypoplasia.
| S-EPMC3591854 | biostudies-literature
Unknown De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
| S-EPMC6035372 | biostudies-literature
Unknown Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly.
| S-EPMC6978259 | biostudies-literature
Unknown Macrocephaly and developmental delay caused by missense variants in RAB5C.
| S-EPMC10586195 | biostudies-literature
Unknown Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations.
| S-EPMC6436622 | biostudies-literature
Unknown 1q42.12q42.2 Deletion in a Child with Midline Defects and Hypoplasia of the Corpus Callosum.
| S-EPMC6528072 | biostudies-literature
Unknown De novo PHIP-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features.
| S-EPMC5111011 | biostudies-literature